Stronger Sell Today EDGE ranks #5209 as SELL CANDIDATE. Weaker Sell
Today EDGE ranks #5209 as SELL CANDIDATE.

EDGE stock Edge Therapeutics

EDGE stock
Edge Therapeutics

Wed 12'th Dec 2018

PERIOD 2018-09-13 - 2018-12-12
CHANGE 0.08%




Request Prediction

Edge Therapeutics Stock Analysis

Technical stock analysis for Wed 12'th Dec 2018

Sell candidate since 2018-10-25 Loss -39.49%
Shorts n/a
Cash n/a
Loans n/a
Beta 3.17
ROA -74.42

Edge Therapeutics gained 0.08% in the last trading day, rising from $0.46 to $0.46 The price has fallen in 6 of the last 10 days and is down by -12.7% for this period. Volume fell in the last day by -221 250 shares, and in total, 355 234 shares bought and sold for approximately $163 710.00. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.


Edge Therapeutics lies in the lower of a very wide and falling trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $0.38 will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -28.86% during the next 3 months and, with 90% probability hold a price between $0.27 and $0.60 at the end of this period.

Click here for today's Top 5 Trending Companies


A buy signal was issued from a pivot bottom point on Tuesday December 11, 2018, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Edge Therapeutics holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $0.50 and $0.65. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 30 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Edge Therapeutics finds support from accumulated volume at $0.46.

Support: $0.46 Price: $0.46 Resistance: $0.52


This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.03 between high and low, or 6.50%. For the last week the stock has had a daily average volatility of 11.87%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High


Edge Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Stronger Sell Today EDGE ranks #5209 as SELL CANDIDATE. Weaker Sell
Today EDGE ranks #5209 as SELL CANDIDATE.